Why work with ImmunoDX?
HIV-1 fitness cost associated with escape from the VRC01 class of CD4 binding site neutralizing antibodies.
Abstract Broadly neutralizing antibodies (bNAbs) have been isolated from selected HIV-1-infected individuals and shown to bind to conserved sites on the envelope glycoprotein (Env). However, circulating plasma virus in these...Read more
Abstract The human immunodeficiency virus (HIV) envelope protein gp120 promotes neuronal injury which is believed to cause HIV-associated neurocognitive disorders. Therefore, blocking the neurotoxic effect of gp120 may lead to...Read more
Expression of CHRFAM7A and CHRNA7 in neuronal cells and post-mortem brain of HIV-infected patients: Considerations for HIV-Associated Neurocognitive Disorder
Products Related to Zika, WestNile, Dengue, Malaria, T.B, Chikungunya, HIV, SARS Product# 1039 HIV-1 YU2 (M Tropic)Envelope Glycoprotein gp41 Product# 1081 HIV-1 gp120 (ADA) Product# 1011 HIV-1 gp120 (subtype C) Product# 1031 HIV-1 gp120 (YU2) Abstract Despite the recent advances in antiretroviral therapy, HIV-1 remains a global...Read more